Josh Bilenker, MD, Former Medical Officer for FDA and Partner at Aisling Capital, Named to NCCN Foundation Board
11:00 EDT 9 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
The NCCN
Foundation, which through private philanthropy and grants advances
the mission of the National
Comprehensive Cancer Network® (NCCN®)
to improve the quality and effectiveness of care for patients with
can...
Other Sources for this Article
NCCN
Katie Kiley Brown, 215-690-0238
brown@nccn.org
More From BioPortfolio on "Josh Bilenker, MD, Former Medical Officer for FDA and Partner at Aisling Capital, Named to NCCN Foundation Board"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
